Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel

Before you go, we thought you'd like these...
Before you go close icon

Pfizer to Buy Anacor in Deal Valued at $5.2 Billion

Pfizer Inc (PFE.N) is buying Anacor Pharmaceuticals Inc (ANAC.O) in a $5.2 billion deal to add an eczema gel to its portfolio, a month after the U.S. drug major scrapped plans to buy Allergan Plc (AGN.N).

Anacor shares rose 54 percent to $98.60 in premarket trading on Monday, just below the offer price of $99.25 per share in cash. The net-of-cash deal value assumes conversion of Anacor's outstanding convertible notes, the companies said in a joint statement.

SEE ALSO: Warren Buffett just announced he has a huge stake in Apple

Pfizer, which is also said to be in talks to buy cancer drug maker Medivation Inc (MDVN.O), seems to be focusing on smaller deals after its $160 billion bid for Dublin-based Allergan failed.

The Anacor deal will give Pfizer access to a non-steroidal topical gel, crisaborole, which is currently under review by the U.S. Food and Drug Administration for the treatment of mild to moderate eczema.

The equity value of the deal is $4.45 billion, based on 44.87 million Anacor's outstanding fully diluted shares as of March 31, according to Thomson Reuters data.

Pfizer said it believed crisaborole has the potential to reach or exceed peak sales of $2 billion.

In the past 15 years, there have been no new molecules approved for eczema - or atopic dermatitis - a common, relapsing, inflammatory skin disorder that affects about 18-25 million people in the United States.

Anacor also holds the rights to Kerydin, a topical treatment for toenail fungus, marketed in the United States by Novartis AG's (NOVN.S) Sandoz unit.

Pfizer's current inflammation and immunology drugs portfolio includes Enbrel and Xeljanz, which target auto-immune diseases.

The company needs to buy new medicines or biotech companies to boost its earnings growth, analysts have said.

Enbrel's patents for Europe expired in February last year and its U.S. patents are set to expire in 2028.

Pfizer shares were down slightly at $33.20 before the bell.

Up to Friday's close, Anacor shares had fallen nearly 60 percent from their record high of $156.93 touched in July.

Centerview Partners and Guggenheim Securities were Pfizer's financial advisers and Citi advised Anacor.

Wachtel Lipton Rosen & Katz is Pfizer's legal adviser for the deal and Davis Polk & Wardwell LLP advised Anacor.

(Reporting by Amrutha Penumudi and Ankur Banerjee in Bengaluru; Editing by Kirti Pandey)

RELATED: The 10 highest-paying companies of 2016

11 PHOTOS
10 highest paying companies of 2016
See Gallery
Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel

10. Cadence Design Systems
Median Total Compensation: $150,010
Median Base Salary: $140,000
Industry: Technology

Photo credit: Facebook

9. Guidewire 
Median Total Compensation: $150,020
Median Base Salary: $135,000 
Industry: Technology

Photo credit: Facebook

8. Boston Consulting Group 
Median Total Compensation: $150,020
Median Base Salary: $147,000 
Industry: Consulting

Photo credit: Facebook

7. Amazon Lab126
Median Total Compensation: $150,100
Median Base Salary: $138,700 
Industry: Technology

Photo credit: Facebook

6. VMware
Median Total Compensation: $152,133
Median Base Salary: $130,000 
Industry: Technology

Photo credit: Facebook

7. Google
Median Total Compensation: $153,750
Median Base Salary: $123,331 
Industry: Technology

Photo credit: AP

4. McKinsey & Company
Median Total Compensation: $155,000
Median Base Salary: $135,000 
Industry: Consulting 

Photo credit: Facebook

3. Juniper Networks
Median Total Compensation: $157,000
Median Base Salary: $135,000 
Industry: Technology

Photo credit: Facebook

2. Strategy&
Median Total Compensation: $160,000
Median Base Salary: $147,000 
Industry: Consulting 

Photo credit: Facebook

1. A.T. Kearney
Median Total Compensation: $167,534
Median Base Salary: $143,620
Industry: Consulting

Photo credit: Facebook

of
SEE ALL
BACK TO SLIDE
SHOW CAPTION +
HIDE CAPTION

Read Full Story

Markets

S&P 500 2,241.35 29.12 1.32%
DJIA 19,549.62 297.84 1.55%
NASDAQ 5,393.76 60.76 1.14%
DAX 11,139.30 152.61 1.39%
HANG SENG 22,861.84 60.92 0.27%
NIKKEI 225 18,765.47 268.78 1.45%
USD (per EUR) 1.06 -0.01 -1.13%
USD (per CHF) 1.02 0.01 0.88%
JPY (per USD) 113.96 0.25 0.22%
GBP (per USD) 1.26 0.00 -0.14%

From Our Partners